Key result
Nonelderly adults with ASCVD face severe financial hardship, with annual out-of-pocket spending exceeding $2,000.
ASCVD is associated with high out-of-pocket spending and financial hardship among nonelderly US adults, even those with health insurance.
A ccording to the American Heart Association, atherosclerotic cardiovascular disease (ASCVD) is not only the leading cause of mortality and morbidity in the United States, but it is also responsible for the highest health care costs for a single class of disease (1). The medical care that accompanies ASCVD often carries large per-capita medical expenditures (1), with an average annual out-of-pocket (OOP) spending of over $2,000, with almost one-half of direct expenditures being related to medication expenses (2). Even among those with health insurance, many people with ASCVD are inadequately protected from financial hardship due to the high costs of insurance, including deductible, copays, and coinsurances.
No takes yet. Share an insight, caveat, or question.
Valero‐Elizondo et al. (2019) studied Atherosclerotic cardiovascular disease (ASCVD). Medical bills was evaluated. Nonelderly U.S. adults with atherosclerotic cardiovascular disease face significant financial hardship, with average annual out-of-pocket spending exceeding $2,000.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: